oxidopamine has been researched along with Body Rocking in 6 studies
Oxidopamine: A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals.
oxidopamine : A benzenetriol that is phenethylamine in which the hydrogens at positions 2, 4, and 5 on the phenyl ring are replaced by hydroxy groups. It occurs naturally in human urine, but is also produced as a metabolite of the drug DOPA (used for the treatment of Parkinson's disease).
| Excerpt | Relevance | Reference |
|---|---|---|
| " When an animal moves on the plate, its movements are sensed by the transducers whose signals are processed by computer to yield measurements of a wide range of behaviors or behavioral attributes, such as locomotor activity, rotation around the center, whole-body tremor, and amphetamine-induced stereotypies." | 3.71 | A force-plate actometer for quantitating rodent behaviors: illustrative data on locomotion, rotation, spatial patterning, stereotypies, and tremor. ( Birkestrand, BR; Chen, R; Fowler, SC; Moss, SJ; Vorontsova, E; Wang, G; Zarcone, TJ, 2001) |
| "A central problem in the treatment of Parkinson's disease (PD) is the development of motor disturbances like L: -DOPA-induced dyskinesia (LID) after long-term treatment." | 1.37 | Flibanserin attenuates L: -DOPA-sensitized contraversive circling in the unilaterally 6-hydroxydopamine-lesioned rat model of Parkinson's disease. ( Beck, J; Gerlach, M; Riederer, P; van den Buuse, M, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gerlach, M | 1 |
| Beck, J | 1 |
| Riederer, P | 1 |
| van den Buuse, M | 1 |
| Chen, XY | 1 |
| Li, J | 1 |
| Qi, WQ | 1 |
| Shen, SH | 1 |
| Ruskin, DN | 1 |
| Bergstrom, DA | 1 |
| Mastropietro, CW | 1 |
| Twery, MJ | 1 |
| Walters, JR | 1 |
| McPherson, RJ | 1 |
| Marshall, JF | 1 |
| Espejo, EF | 1 |
| Miñano, J | 1 |
| Fowler, SC | 1 |
| Birkestrand, BR | 1 |
| Chen, R | 1 |
| Moss, SJ | 1 |
| Vorontsova, E | 1 |
| Wang, G | 1 |
| Zarcone, TJ | 1 |
6 other studies available for oxidopamine and Body Rocking
| Article | Year |
|---|---|
Flibanserin attenuates L: -DOPA-sensitized contraversive circling in the unilaterally 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
Topics: Analysis of Variance; Animals; Antiparkinson Agents; Benzimidazoles; Disease Models, Animal; Dose-Re | 2011 |
Experimental change on dopaminergic neurons in striatum of Parkinson disease rats.
Topics: Animals; Apomorphine; Behavior, Animal; Corpus Striatum; Disease Models, Animal; Dopamine; Dopamine | 2007 |
Dopamine agonist-mediated rotation in rats with unilateral nigrostriatal lesions is not dependent on net inhibitions of rate in basal ganglia output nuclei.
Topics: Animals; Apomorphine; Basal Ganglia; Behavior, Animal; Corpus Striatum; Dopamine Agonists; Electroph | 1999 |
Substantia nigra glutamate antagonists produce contralateral turning and basal ganglia Fos expression: interactions with D1 and D2 dopamine receptor agonists.
Topics: Animals; Basal Ganglia; Behavior, Animal; Dopamine Agonists; Drug Synergism; Excitatory Amino Acid A | 2000 |
Adrenergic hyperactivity and metanephrine excess in the nucleus accumbens after prefrontocortical dopamine depletion.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Anxiety; Behavior, Animal; Darkness; Dopamine; Epinephrine; | 2001 |
A force-plate actometer for quantitating rodent behaviors: illustrative data on locomotion, rotation, spatial patterning, stereotypies, and tremor.
Topics: Amphetamine; Animals; Behavior, Animal; Biomechanical Phenomena; Central Nervous System; Dopamine Up | 2001 |